Delivery Order SPE2DB20D1004-SPE2DB24FG6H4

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,565,095 units of the prescription drug escitalopram 10mg tablets. The delivery order, valued at $5,737.94, is a firm fixed-price contract with an ultimate completion date of August 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.98 firm fixed price contract is for the delivery of 4,563,337,276 units of the generic drug escitalopram 10 mg tablets. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. There was no set-aside designation for this contract. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,461.02 firm fixed-price contract is for the delivery of 4,562,019,744 units of the prescription drug Escitalopram 10 mg tablet. The contract has an ultimate completion date of September 1, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,560,733,613 units of the prescription drug Escitalopram 10 mg tablet, with a ceiling value of $2,072.10. The contract is a firm fixed-price delivery order with an ultimate completion date of April 27, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,239.69 firm fixed price delivery order is for the supply of 4,565,548,532 units of the pharmaceutical drug Escitalopram 10 mg tablets. The contract has an ultimate completion date of August 23, 2024 and was awarded on August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,034 units of the drug Escitalopram 10 mg tablets. The contract has a ceiling value of $6,074.93 and a completion date of February 24, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,730.24, is for the delivery of 4,563,151,698 units of the prescription medication Escitalopram 10 mg tablets. The contract has a completion date of December 21, 2023 and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,256.90, is for the supply of 4,563,653,525 units of the medication Escitalopram 10 mg tablet. The contract has a period of performance through February 14, 2024 and utilizes a firm fixed price pricing structure. This contract is not designated as a set-aside. AmerisourceBergen holds a large...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,748.20 firm fixed-price delivery order is for the supply of 4,563,865,533 units of the prescription medication escitalopram 20 mg tablet. The contract has an ultimate completion date of March 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 1,000 units of the medication Escitalopram 10 mg tablet, with a potential value of $2,836.32 and a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG6H4
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,452.16, is for the delivery of 4,565,392 units of 20 mg Escitalopram tablets. The contract has an ultimate completion date of August 9, 2024 and was awarded on August 8, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:13 PM